Standard BioTools Q2 2025 Earnings Preview
Source: SeekingAlpha
2025-08-08 12:35:23 ET
More on Standard BioTools
- Standard BioTools: Too Early To Determine The Fate Of This Turnaround
- Standard BioTools jumps on sale of SomaLogic to Illumina
- Seeking Alpha’s Quant Rating on Standard BioTools
- Historical earnings data for Standard BioTools
- Financial information for Standard BioTools
Read the full article on Seeking Alpha
For further details see:
Standard BioTools Q2 2025 Earnings Preview
Standard BioTools Inc.
NASDAQ: LAB
LAB Trading
0.16% G/L:
$0.9336 Last:
1,106,612 Volume:
$0.94 Open:
LAB Latest News
February 24, 2026 04:10:00 pm
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
LAB Stock Data
$476,861,113
295,500,064
21.04%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
